Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Tsukagoshi

Showing results (151-160 of 178) with videos related to

Pageof 18
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1992
[Anti-emetic effect and safety of consecutive use of ondansetron injection in cisplatin-induced nausea and emesis]Y Akasaka, T Taguchi, K Ota, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1992
[Investigation of anti-emetic effect of ondansetron tablet in multiple doses on nausea and emesis associated with cisplatin]M Suminaga, H Furue, T Taguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1992
[Evaluation of SN-307 (ondansetron), given intravenously for the treatment of nausea and vomiting caused by anticancer drugs including cisplatin-open study]M Ikeda, T Taguchi, K Ota, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1995
[The clinical phase I study of TNP-351. The TNP-351 Research Committee]T Taguchi, H Niitani, H Furue, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1997
[TUT-7 early phase II clinical study for various solid tumors and hematologic malignancies]T Taguchi, A Wakui, H Niitani, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1992
[Anti-emetic effect and safety of single dose of ondansetron injection in double-blind comparison study with placebo]J Ohta, T Taguchi, H Furue, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1992
[Evaluation of SN-307 (ondansetron), given intravenously in the treatment of nausea and vomiting caused by anticancer drugs including cisplatin--a placebo-controlled, double-blind comparative study]M Ikeda, T Taguchi, K Ota, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1993
[Phase I Study of RA-700. RA-700 Clinical Study Group]H Majima, S Tsukagoshi, H Furue, et al.
Artificial Organs|November 1, 1984
Quantitative approach to determine the application time of the left ventricular assist deviceN Inou, I Fujimasa, K Imachi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1992
[Examination of anti-emetic effect and safety of multiple intravenous doses of ondansetron in patients receiving nonplatinum anti-cancer drugs]N Nukariya, H Niitani, T Taguchi, et al.
Pageof 18

Showing results (151-160 of 178) with videos related to

Sort By:
Pageof 18
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1992
[Anti-emetic effect and safety of consecutive use of ondansetron injection in cisplatin-induced nausea and emesis]Y Akasaka, T Taguchi, K Ota, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1992
[Investigation of anti-emetic effect of ondansetron tablet in multiple doses on nausea and emesis associated with cisplatin]M Suminaga, H Furue, T Taguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1992
[Evaluation of SN-307 (ondansetron), given intravenously for the treatment of nausea and vomiting caused by anticancer drugs including cisplatin-open study]M Ikeda, T Taguchi, K Ota, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1995
[The clinical phase I study of TNP-351. The TNP-351 Research Committee]T Taguchi, H Niitani, H Furue, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1997
[TUT-7 early phase II clinical study for various solid tumors and hematologic malignancies]T Taguchi, A Wakui, H Niitani, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1992
[Anti-emetic effect and safety of single dose of ondansetron injection in double-blind comparison study with placebo]J Ohta, T Taguchi, H Furue, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1992
[Evaluation of SN-307 (ondansetron), given intravenously in the treatment of nausea and vomiting caused by anticancer drugs including cisplatin--a placebo-controlled, double-blind comparative study]M Ikeda, T Taguchi, K Ota, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1993
[Phase I Study of RA-700. RA-700 Clinical Study Group]H Majima, S Tsukagoshi, H Furue, et al.
Artificial Organs|November 1, 1984
Quantitative approach to determine the application time of the left ventricular assist deviceN Inou, I Fujimasa, K Imachi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1992
[Examination of anti-emetic effect and safety of multiple intravenous doses of ondansetron in patients receiving nonplatinum anti-cancer drugs]N Nukariya, H Niitani, T Taguchi, et al.
Pageof 18